9PA0 | pdb_00009pa0

Hybrid-1 form of human telomere DNA quadruplex with wild-type 5'-flanking in K+ solution

  • Classification: DNA
  • Organism(s): Homo sapiens
  • Mutation(s): No 

  • Deposited: 2025-06-25 Released: 2026-05-06 
  • Deposition Author(s): Dickerhoff, J., Yang, D.
  • Funding Organization(s): National Institutes of Health/National Cancer Institute (NIH/NCI)

Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report

Validation slider image for 9PA0

This is version 1.1 of the entry. See complete history

Literature

NMR structure study of DNA G-quadruplexes and ligand complexes.

Dickerhoff, J.Yang, D.

(2026) Prog Nucl Magn Reson Spectrosc 154-155: 101597-101597

  • DOI: https://doi.org/10.1016/j.pnmrs.2026.101597
  • Primary Citation Related Structures: 
    9PA0

  • PubMed Abstract: 

    G-quadruplexes (G4s) have emerged as one of the most exciting nucleic acid secondary structures. G-quadruplexes are non-canonical, four-stranded nucleic acid structures formed in sequences with consecutive runs of guanine bases. Unlike duplex DNA, G-quadruplexes are globularly folded structures and can readily form under physiologically relevant solution conditions. G-quadruplex structures have been found in biologically significant nucleic acid regions, including human telomeres, oncogene-promoter regions, replication initiation sites, and untranslated regions (UTRs) of mRNA. They have been shown to be important regulatory motifs in a number of critical cellular processes including gene transcription, translation, DNA replication, and genomic stability. G-quadruplexes have become a new class of molecular targets for drug development. Nuclear magnetic resonance (NMR) spectroscopy is the major method for studying the structures of G-quadruplexes under physiologically relevant solution conditions. NMR spectroscopy is a powerful tool for studying G-quadruplex interactions with small molecule ligands in solution. To date, most G-quadruplex structures have been determined using NMR techniques. This review provides a comprehensive overview of the NMR methods used to determine DNA G-quadruplex structures and their ligand interactions in solution. It covers essential steps such as resonance assignment, which is foundational for all NMR studies, as well as the determination of G-quadruplex folding topology and structure using NMR spectroscopy. Additionally, it discusses NMR structural studies of small molecule interactions with DNA G-quadruplexes. Through examples of NMR-based structure characterization of G-quadruplexes and G-quadruplex-ligand complexes, this review illustrates the rich information that NMR spectroscopy can provide, demonstrating its applicability to a broad range of biologically relevant DNA G-quadruplexes and their ligand interactions.


  • Organizational Affiliation
    • Purdue University, College of Pharmacy, Borch Department of Medicinal Chemistry and Molecular Pharmacology, 575 W Stadium Ave, West Lafayette, IN 47907, USA.

Macromolecule Content 

  • Total Structure Weight: 7.6 kDa 
  • Atom Count: 506 
  • Modeled Residue Count: 24 
  • Deposited Residue Count: 24 
  • Unique nucleic acid chains: 1

Macromolecules

Find similar nucleic acids by:  Sequence
Entity ID: 1
MoleculeChains LengthOrganismImage
DNA (5'-D(*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*GP*A)-3')A [auth X]24Homo sapiens
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Cancer Institute (NIH/NCI)United StatesR01CA177585
National Institutes of Health/National Cancer Institute (NIH/NCI)United StatesU01CA240346
National Institutes of Health/National Cancer Institute (NIH/NCI)United StatesP30CA023168

Revision History  (Full details and data files)

  • Version 1.0: 2026-05-06
    Type: Initial release
  • Version 1.1: 2026-09-09
    Changes: Database references